Michigan Collaborative Thrombosis Prevention Pilot

密歇根州协作血栓试验(Michigan Pilot)是一个三中心项目，建立在密歇根州血友病治疗中心(HTCS)提供的全面出血性疾病护理模式的基础上，并将扩展该模式，为患有血栓形成、血栓形成和血栓相关并发症的患者提供服务。 密歇根血友病基金会(HFM)将管理资金，并为该项目提供协调、规划和其他行政支持。试点将侧重于开发一个全面的患者登记和临床数据库，以帮助疾病控制和预防中心努力更好地了解导致血栓形成的遗传和环境风险因素。临床和研究中心位于以下学术医疗中心：密歇根大学安娜堡分校；密歇根州立大学东兰辛分校；韦恩州立大学底特律分校。 试点网站还将独立和协作地制定成人和儿科筛查和治疗方案，为临床翻译研究提供框架，以确定最佳治疗和预防干预措施。试点网站将与全国各地的资助网站合作，并将与患者组织合作，提高人们对血栓形成治疗和预防选择的认识。

The Michigan Collaborative Thrombosis Pilot(MichiganPilot)is a tri-centerproject that builds on and will expand the model of comprehensive bleeding disorders care provided by hemophilia treatment centers (HTCs) in the state of Michigan to serve patients with thrombophilia, thrombosis and thrombosis-related complications. The Hemophilia Foundationof Michigan(HFM) will administer funding and provide coordination, planning and otheradministrative support for the project. The pilot will focus on the development of a comprehensive registryof patients and clinical database to assist the Centers for Disease Control and Prevention in its efforts to better understand the genetic and environmental risk factors that contribute to thrombosis. The clinical and research sites are located in the following academic medical centers: Universityof Michigan, AnnArbor;,MichiganState University,East Lansing; Wayne StateUniversity,Detroit. Pilot sites will also work independently and collaboratively to develop adult and pediatric screening and treatment protocols to provide a framework for clinical translation research to determine optimal therapies and prevention interventions. Pilot sites will collaborate with funded sites across the country and will work with patient organizations to promote awareness about thrombosis treatment and prevention options.